# Chemomab Therapeutics Ltd.: Form 8-K, filed Jun 16, 2023

- Company: [Chemomab Therapeutics Ltd.](/companies/cmmb.md) (CIK 1534248)
- Form: 8-K
- Filed: 2023-06-16
- Accepted by EDGAR: Jun 16, 2023, 16:01 ET
- Period: 2023-06-14
- Accession: 0001178913-23-002225
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1534248/000117891323002225/zk2329883.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534248/000117891323002225/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534248/000117891323002225/zk2329883.htm

Filed Jun 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001178913-23-002225. Last ingested by Listed: Nov 3, 2026, 08:33 ET. No prices; not investment advice.